1. A comparison of health‐related quality of life (health utility) between insulin degludec and insulin glargine: a meta‐analysis of phase 3 trials. Issue 6 (1st April 2013) Authors: Freemantle, N.; Evans, M.; Christensen, T.; Wolden, M. L.; Bjorner, J. B. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 6(2013:Jun.) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia. Issue 4 (13th December 2015) Authors: Heller, S.; Mathieu, C.; Kapur, R.; Wolden, M. L.; Zinman, B. Journal: Diabetic medicine Issue: Volume 33:Issue 4(2016:Apr.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non‐interventional study (EU‐TREAT). Issue 7 (2nd May 2019) Authors: Knudsen, S. T.; Lapolla, A.; Schultes, B.; Tentolouris, N.; Catarig, A.‐M.; Wolden, M. L.; Siegmund, T. Journal: Diabetic medicine Issue: Volume 36:Issue 7(2019) Page Start: 868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2‐year trial in insulin‐naïve patients with type 2 diabetes. Issue 9 (27th February 2014) Authors: Rodbard, H. W.; Cariou, B.; Zinman, B.; Handelsman, Y.; Wolden, M. L.; Rana, A.; Mathieu, C. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 9(2014:Sep.) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management. Issue 4 (19th May 2016) Authors: Kolotkin, R. L.; Fujioka, K.; Wolden, M. L.; Brett, J. H.; Bjorner, J. B. Journal: Clinical obesity Issue: Volume 6:Issue 4(2016) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Insulin degludec improves health‐related quality of life (SF‐36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta‐analysis of phase 3a trials. Issue 2 (21st January 2013) Authors: Freemantle, N.; Meneghini, L.; Christensen, T.; Wolden, M. L.; Jendle, J.; Ratner, R. Journal: Diabetic medicine Issue: Volume 30:Issue 2(2013:Feb.) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗